Vitamins E and C: Effects on matrix components in the vascular system

Vitamin-Binding Proteins: Functional Consequences

Volumn , Issue , 2013, Pages 127-156

  Zingg, Jean Marc ^a   Meydani, Mohsen ^a   Azzi, Angelo ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85054719198     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b15313     Document Type: Chapter

References (252)

1. ABE, H., IEHARA, N., UTSUNOMIYA, K., KITA, T. & DOI, T. 1999. A vitamin D analog regulates mesangial cell smooth muscle phenotypes in a transforming growth factor-beta type II receptor-mediated manner. J Biol Chem, 274, 20874-8.
2. ABUDU, N., MILLER, J. J., ATTAELMANNAN, M. & LEVINSON, S. S. 2004. Vitamins in human arteriosclerosis with emphasis on vitamin C and vitamin E. Clin Chim Acta, 339, 11-25.
3. ALCAIN, F. J. & BURON, M. I. 1994. Ascorbate on cell growth and differentiation. J Bioenerg Biomembr, 26, 393-8.
4. ALEXANDER, R. W. & DZAU, V. J. 2000. Vascular biology: The past 50 years. Circulation, 102, IV112-6.
5. AMES, B. N., SHIGENAGA, M. K. & HAGEN, T. M. 1993. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A, 90, 7915-22.
6. ANDERSEN, M., LENHARD, B., WHATLING, C., ERIKSSON, P. & ODEBERG, J. 2006. Alternative promoter usage of the membrane glycoprotein CD36. BMC Mol Biol, 7, 8.
7. ANTONIADES, C., TOUSOULIS, D., TENTOLOURIS, C., TOUTOUZAS, P. & STEFANADIS, C. 2003. Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice. Herz, 28, 628-38.
8. ARAKAWA, E., HASEGAWA, K., YANAI, N., OBINATA, M. & MATSUDA, Y. 2000. A mouse bone marrow stromal cell line, TBR-B, shows inducible expression of smooth muscle-specific genes. FEBS Lett, 481, 193-6.
9. ARATRI, E., SPYCHER, S. E., BREYER, I. & AZZI, A. 1999. Modulation of alpha-tropomyosin expression by alpha-tocopherol in rat vascular smooth muscle cells. FEBS Lett, 447, 91-4.
10. ARRIGONI, O. & DE TULLIO, M. C. 2002. Ascorbic acid: Much more than just an antioxidant. Biochim Biophys Acta, 1569, 1-9.
11. ASLEH, R. & LEVY, A. P. 2010. Divergent effects of alpha-tocopherol and vitamin C on the generation of dysfunctional HDL associated with diabetes and the Hp 2-2 genotype. Antioxid Redox Signal, 12, 209-17.
12. AXEL, D. I., FRIGGE, A., DITTMANN, J., RUNGE, H., SPYRIDOPOULOS, I., RIESSEN, R., VIEBAHN, R. & KARSCH, K. R. 2001. All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells. Cardiovasc Res, 49, 851-62.
13. AZZI, A., BOSCOBOINIK, D., MARILLEY, D., OZER, N. K., STAUBLE, B. & TASINATO, A. 1995. Vitamin E: A sensor and an information transducer of the cell oxidation state. Am J Clin Nutr, 62, 1337S-1346S.
14. BJELAKOVIC, G., NIKOLOVA, D., GLUUD, L. L., SIMONETTI, R. G. & GLUUD, C. 2007. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. Jama, 297, 842-57.
15. BLOM, I. E., VAN DIJK, A. J., WIETEN, L., DURAN, K., ITO, Y., KLEIJ, L., DENICHILO, M., RABELINK, T. J., WEENING, J. J., ATEN, J. & GOLDSCHMEDING, R. 2001. In vitro evidence for differential involvement of CTGF, TGFbeta, and PDGF-BB in mesangial response to injury. Nephrol Dial Transplant, 16, 1139-48.
16. BLUM, S., VARDI, M., BROWN, J. B., RUSSELL, A., MILMAN, U., SHAPIRA, C., LEVY, N. S., MILLER-LOTAN, R., ASLEH, R. & LEVY, A. P. 2010. Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype. Pharmacogenomics, 11, 675-84.
17. BREYER, I. & AZZI, A. 2001. Differential inhibition by alpha-and beta-tocopherol of human erythroleukemia cell adhesion: Role of integrins. Free Radic Biol Med, 30, 1381-9.
18. BRIGELIUS-FLOHE, R. 2003. Vitamin E and drug metabolism. Biochem Biophys Res Commun, 305, 737-40.
19. BRIGELIUS-FLOHE, R., KELLY, F. J., SALONEN, J. T., NEUZIL, J., ZINGG, J. M. & AZZI, A. 2002. The European perspective on vitamin E: Current knowledge and future research. Am J Clin Nutr, 76, 703-16.
20. BRIGELIUS-FLOHE, R. & TRABER, M. G. 1999. Vitamin E: Function and metabolism. FASEB J, 13, 1145-55.
21. BUETTNER, G. R. 1993. The pecking order of free radicals and antioxidants: Lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys, 300, 535-43.
22. BURK, R. F., CHRISTENSEN, J. M., MAGUIRE, M. J., AUSTIN, L. M., WHETSELL, W. O., JR., MAY, J. M., HILL, K. E. & EBNER, F. F. 2006. A combined deficiency of vitamins E and C causes severe central nervous system damage in guinea pigs. J Nutr, 136, 1576-81.
23. CACHIA, O., BENNA, J. E., PEDRUZZI, E., DESCOMPS, B., GOUGEROT-POCIDALO, M. A. & LEGER, C. L. 1998. Alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation. J Biol Chem, 273, 32801-5.
24. CARDUS, A., PANIZO, S., ENCINAS, M., DOLCET, X., GALLEGO, C., ALDEA, M., FERNANDEZ, E. & VALDIVIELSO, J. M. 2009. 1,25-dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter. Atherosclerosis, 204, 85-9.
25. CARDUS, A., PARISI, E., GALLEGO, C., ALDEA, M., FERNANDEZ, E. & VALDIVIELSO, J. M. 2006. 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int, 69, 1377-84.
26. CARR, A. C. & FREI, B. 1999. Does vitamin C act as pro-oxidant under physiological conditions? FASEB J, 13, 1007-24.
27. CECCARELLI, S., CARDINALI, G., ASPITE, N., PICARDO, M., MARCHESE, C., TORRISI, M. R. & MANCINI, P. 2007. Cortactin involvement in the keratinocyte growth factor and fibroblast growth factor 10 promotion of migration and cortical actin assembly in human keratinocytes. Exp Cell Res, 313, 1758-77.
28. CHAN, A. C. 1993. Partners in defense, vitamin E and vitamin C. Can J Physiol Pharmacol, 71, 725-31.
29. CHANDRA, V., JASTI, J., KAUR, P., BETZEL, C., SRINIVASAN, A. & SINGH, T. P. 2002. First structural evidence of a specific inhibition of phospholipase A2 by alpha-tocopherol (vitamin E) and its implications in inflammation: Crystal structure of the complex formed between phospholipase A2 and alpha-tocopherol at 1.8 A resolution. J Mol Biol, 320, 215-22.
30. CHAUMONTET, C., BEX, V., VERAN, F. & MARTEL, P. 2008. The vitamin E analog tocopherol succinate strongly inhibits gap junctional intercellular communication in rat liver epithelial cells (IAR203). J Nutr Biochem, 19, 263-8.
31. CHEN, C. C., CHEN, N. & LAU, L. F. 2001. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem, 276, 10443-52.
32. CHEUNG, L., ANDERSEN, M., GUSTAVSSON, C., ODEBERG, J., FERNANDEZ-PEREZ, L., NORSTEDT, G. & TOLLET-EGNELL, P. 2007. Hormonal and nutritional regulation of alternative CD36 transcripts in rat liver-a role for growth hormone in alternative exon usage. BMC Mol Biol, 8, 60.
33. CHIQUET, M., RENEDO, A. S., HUBER, F. & FLUCK, M. 2003. How do fibroblasts translate mechanical signals into changes in extracellular matrix production? Matrix Biol, 22, 73-80.
34. CHRISTEN, T., BOCHATON-PIALLAT, M. L., NEUVILLE, P., RENSEN, S., REDARD, M., VAN EYS, G. & GABBIANI, G. 1999. Cultured porcine coronary artery smooth muscle cells. A new model with advanced differentiation. Circ Res, 85, 99-107.
35. COUFFINHAL, T., KEARNEY, M., WITZENBICHLER, B., CHEN, D., MUROHARA, T., LOSORDO, D. W., SYMES, J. & ISNER, J. M. 1997. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol, 150, 1673-85.
36. DAGHINI, E., ZHU, X. Y., VERSARI, D., BENTLEY, M. D., NAPOLI, C., LERMAN, A. & LERMAN, L. O. 2007. Antioxidant vitamins induce angiogenesis in the normal pig kidney. Am J Physiol Renal Physiol, 293, F371-81.
37. DAVIDSON, J. M., LUVALLE, P. A., ZOIA, O., QUAGLINO, D., JR. & GIRO, M. 1997. Ascorbate differentially regulates elastin and collagen biosynthesis in vascular smooth muscle cells and skin fibroblasts by pretranslational mechanisms. J Biol Chem, 272, 345-52.
38. DE CLERCK, Y. A. & JONES, P. A. 1980. The effect of ascorbic acid on the nature and production of collagen and elastin by rat smooth-muscle cells. Biochem J, 186, 217-25.
39. DE PASCALE, M. C., BASSI, A. M., PATRONE, V., VILLACORTA, L., AZZI, A. & ZINGG, J. M. 2006. Increased expression of transglutaminase-1 and PPARgamma after vitamin E treatment in human keratinocytes. Arch Biochem Biophys, 447, 97-106.
40. DECLERCK, Y. A. & JONES, P. A. 1980. Effect of ascorbic acid on the resistance of the extracellular matrix to hydrolysis by tumor cells. Cancer Res, 40, 3228-31.
41. DEL BELLO, B., MAELLARO, E., SUGHERINI, L., SANTUCCI, A., COMPORTI, M. & CASINI, A. F. 1994. Purification of NADPH-dependent dehydroascorbate reductase from rat liver and its identification with 3 alpha-hydroxysteroid dehydrogenase. Biochem J, 304 (Pt 2), 385-90.
42. DESRUMAUX, C., RISOLD, P. Y., SCHROEDER, H., DECKERT, V., MASSON, D., ATHIAS, A., LAPLANCHE, H., LE GUERN, N., BLACHE, D., JIANG, X. C., TALL, A. R., DESOR, D. & LAGROST, L. 2005. Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice. FASEB J, 19, 296-7.
43. DI SARIO, A., CANDELARESI, C., OMENETTI, A. & BENEDETTI, A. 2007. Vitamin E in chronic liver diseases and liver fibrosis. Vitam Horm, 76, 551-73.
44. DORING, F., RIMBACH, G. & LODGE, J. K. 2004. In silico search for single nucleotide polymorphisms in genes important in vitamin E homeostasis. IUBMB Life, 56, 615-20.
45. DUARTE, T. L., COOKE, M. S. & JONES, G. D. 2009. Gene expression profiling reveals new protective roles for vitamin C in human skin cells. Free Radic Biol Med, 46, 78-87.
46. ERICHSEN, H. C., ENGEL, S. A., ECK, P. K., WELCH, R., YEAGER, M., LEVINE, M., SIEGA-RIZ, A. M., OLSHAN, A. F. & CHANOCK, S. J. 2006. Genetic variation in the sodium-dependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery. Am J Epidemiol, 163, 245-54.
47. EYRE, N. S., CLELAND, L. G., TANDON, N. N. & MAYRHOFER, G. 2007. Importance of the carboxyl terminus of FAT/CD36 for plasma membrane localization and function in long-chain fatty acid uptake. J Lipid Res, 48, 528-42.
48. FANALI, G., FASANO, M., ASCENZI, P., ZINGG, J.-M. & AZZI, A. 2013. α-Tocopherol binding to human serum albumin. Biofactors. Epub ahead of print. DOI: 10.1002/biof.1070.
49. FANG, J. C., KINLAY, S., BELTRAME, J., HIKITI, H., WAINSTEIN, M., BEHRENDT, D., SUH, J., FREI, B., MUDGE, G. H., SELWYN, A. P. & GANZ, P. 2002. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: A randomised trial. Lancet, 359, 1108-13.
50. FARQUHARSON, C., BERRY, J. L., MAWER, E. B., SEAWRIGHT, E. & WHITEHEAD, C. C. 1998. Ascorbic acid-induced chondrocyte terminal differentiation: The role of the extracellular matrix and 1,25-dihydroxyvitamin D. Eur J Cell Biol, 76, 110-8.
51. FIORITO, C., RIENZO, M., CRIMI, E., ROSSIELLO, R., BALESTRIERI, M. L., CASAMASSIMI, A., MUTO, F., GRIMALDI, V., GIOVANE, A., FARZATI, B., MANCINI, F. P. & NAPOLI, C. 2008. Antioxidants increase number of progenitor endothelial cells through multiple gene expression pathways. Free Radic Res, 42, 754-62.
52. FOLGER, P. A., ZEKARIA, D., GROTENDORST, G. & MASUR, S. K. 2001. Transforming growth factor-beta-stimulated connective tissue growth factor expression during corneal myofibroblast differentiation. Invest Ophthalmol Vis Sci, 42, 2534-41.
53. FRANCESCHI, R. T. & IYER, B. S. 1992. Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res, 7, 235-46.
54. FRANCESCHI, R. T., IYER, B. S. & CUI, Y. 1994. Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res, 9, 843-54.
55. FREI, B., ENGLAND, L. & AMES, B. N. 1989. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A, 86, 6377-81.
56. FREI, B., KEANEY, J. F., JR., RETSKY, K. L. & CHEN, K. 1996. Vitamins C and E and LDL oxidation. Vitam Horm, 52, 1-34.
57. FURMANIAK-KAZMIERCZAK, E., CRAWLEY, S. W., CARTER, R. L., MAURICE, D. H. & COTE, G. P. 2007. Formation of extracellular matrix-digesting invadopodia by primary aortic smooth muscle cells. Circ Res, 100, 1328-36.
58. GEESIN, J. C., DARR, D., KAUFMAN, R., MURAD, S. & PINNELL, S. R. 1988. Ascorbic acid specifically increases type I and type III procollagen messenger RNA levels in human skin fibroblast. J Invest Dermatol, 90, 420-4.
59. GESS, B., ROHR, D., FLEDRICH, R., SEREDA, M. W., KLEFFNER, I., HUMBERG, A., NOWITZKI, J., STRECKER, J. K., HALFTER, H. & YOUNG, P. 2011. Sodium-dependent vitamin C transporter 2 deficiency causes hypomyelination and extracellular matrix defects in the peripheral nervous system. J Neurosci, 31, 17180-92.
60. GHOSH, P. K., VASANJI, A., MURUGESAN, G., EPPELL, S. J., GRAHAM, L. M. & FOX, P. L. 2002. Membrane microviscosity regulates endothelial cell motility. Nat Cell Biol, 4, 894-900.
61. GINTER, E., BOBEK, P., KUBEC, F., VOZAR, J. & URBANOVA, D. 1982. Vitamin C in the control of hypercholesterolemia in man. Int J Vitam Nutr Res Suppl, 23, 137-52.
62. GOTI, D., HAMMER, A., GALLA, H. J., MALLE, E. & SATTLER, W. 2000. Uptake of lipoprotein-associated alpha-tocopherol by primary porcine brain capillary endothelial cells. J Neurochem, 74, 1374-83.
63. GOTI, D., HRZENJAK, A., LEVAK-FRANK, S., FRANK, S., VAN DER WESTHUYZEN, D. R., MALLE, E. & SATTLER, W. 2001. Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E. J Neurochem, 76, 498-508.
64. GOTI, D., REICHER, H., MALLE, E., KOSTNER, G. M., PANZENBOECK, U. & SATTLER, W. 1998. High-density lipoprotein (HDL3)-associated alpha-tocopherol is taken up by HepG2 cells via the selective uptake pathway and resecreted with endogenously synthesized apo-lipoprotein B-rich lipoprotein particles. Biochem J, 332, 57-65.
65. GREENWALD, R. A. & MOY, W. W. 1980. Effect of oxygen-derived free radicals on hyaluronic acid. Arthritis Rheum, 23, 455-63.
66. GROSSMAN, S. & WAKSMAN, E. G. 1984. New aspects of the inhibition of soybean lipoxygenase by alpha-tocopherol. Evidence for the existence of a specific complex. Int J Biochem, 16, 281-9.
67. GROTENDORST, G. R., OKOCHI, H. & HAYASHI, N. 1996. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ, 7, 469-80.
68. HALLER, H., LINDSCHAU, C., QUASS, P., DISTLER, A. & LUFT, F. C. 1995. Differentiation of vascular smooth muscle cells and the regulation of protein kinase C-alpha. Circ Res, 76, 21-9.
69. HALPNER, A. D., HANDELMAN, G. J., HARRIS, J. M., BELMONT, C. A. & BLUMBERG, J. B. 1998. Protection by vitamin C of loss of vitamin E in cultured rat hepatocytes. Arch Biochem Biophys, 359, 305-9.
70. HEDIGER, M. A. 2002. New view at C. Nat Med, 8, 445-6.
71. HELLER, R., HECKER, M., STAHMANN, N., THIELE, J. J., WERNER-FELMAYER, G. & WERNER, E. R. 2004a. Alpha-tocopherol amplifies phosphorylation of endothelial nitric oxide synthase at serine 1177 and its short-chain derivative trolox stabilizes tetrahydrobiopterin. Free Radic Biol Med, 37, 620-31.
72. HELLER, R., WERNER-FELMAYER, G. & WERNER, E. R. 2004b. Alpha-tocopherol and endothelial nitric oxide synthesis. Ann N Y Acad Sci, 1031, 74-85.
73. HELLMAN, L. & BURNS, J. J. 1958. Metabolism of L-ascorbic acid-1-C14 in man. J Biol Chem, 230, 923-30.
74. HENTATI, A., DENG, H. X., HUNG, W. Y., NAYER, M., AHMED, M. S., HE, X., TIM, R., STUMPF, D. A., SIDDIQUE, T. & AHMED 1996. Human alpha-tocopherol transfer protein: Gene structure and mutations in familial vitamin E deficiency. Ann Neurol, 39, 295-300.
75. HORSKA, A., MISLANOVA, C., BONASSI, S., CEPPI, M., VOLKOVOVA, K. & DUSINSKA, M. 2011. Vitamin C levels in blood are influenced by polymorphisms in glutathione S-transferases. Eur J Nutr, 50, 437-46.
76. HUEBBE, P., LODGE, J. K. & RIMBACH, G. 2010. Implications of apolipoprotein E genotype on inflammation and vitamin E status. Mol Nutr Food Res, 54, 623-30.
77. HULSE, J. D., ELLIS, S. R. & HENDERSON, L. M. 1978. Carnitine biosynthesis. Beta-hydroxylation of trimethyllysine by an alpha-ketoglutarate-dependent mitochondrial dioxygenase. J Biol Chem, 253, 1654-9.
78. IQBAL, J. & HUSSAIN, M. M. 2009. Intestinal lipid absorption. Am J Physiol Endocrinol Metab, 296, E1183-94.
79. ITO, S., HYODO, T., HASEGAWA, H., YUAN, H., HAMAGUCHI, M. & SENGA, T. 2010. PI3K/Akt signaling is involved in the disruption of gap junctional communication caused by v-Src and TNF-alpha. Biochem Biophys Res Commun, 400, 230-5.
80. IVANOV, V. O., IVANOVA, S. V. & NIEDZWIECKI, A. 1997. Ascorbate affects proliferation of guinea-pig vascular smooth muscle cells by direct and extracellular matrix-mediated effects. J Mol Cell Cardiol, 29, 3293-303.
81. IWAMA, M., HONDA, A., OHOHASHI, Y., SAKAI, T. & MORI, Y. 1985. Alterations in glycosaminoglycans of the aorta of vitamin E-deficient rats. Atherosclerosis, 55, 115-23.
82. JIALAL, I. & DEVARAJ, S. 2003. Antioxidants and atherosclerosis: Don’t throw out the baby with the bath water. Circulation, 107, 926-8.
83. JIALAL, I. & FULLER, C. J. 1995. Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis. Can J Cardiol, 11 Suppl G, 97G-103G.
84. JIALAL, I., VEGA, G. L. & GRUNDY, S. M. 1990. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis, 82, 185-91.
85. JIANG, Q. & AMES, B. N. 2003. Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J, 17, 816-22.
86. JIANG, Q., CHRISTEN, S., SHIGENAGA, M. K. & AMES, B. N. 2001. Gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr, 74, 714-22.
87. JIANG, Q., ELSON-SCHWAB, I., COURTEMANCHE, C. & AMES, B. N. 2000. Gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci U S A, 97, 11494-99.
88. JIANG, X. C., TALL, A. R., QIN, S., LIN, M., SCHNEIDER, M., LALANNE, F., DECKERT, V., DESRUMAUX, C., ATHIAS, A., WITZTUM, J. L. & LAGROST, L. 2002. Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. J Biol Chem, 277, 31850-6.
89. JOHNYKUTTY, S., TANG, P., ZHAO, H., HICKS, D. G., YEH, S. & WANG, X. 2009. Dual expression of alpha-tocopherol-associated protein and estrogen receptor in normal/benign human breast luminal cells and the downregulation of alpha-tocopherol-associated protein in estrogen-receptor-positive breast carcinomas. Mod Pathol, 22, 770-5.
90. KAGAN, V. E., SERBINOVA, E. A., FORTE, T., SCITA, G. & PACKER, L. 1992. Recycling of vitamin E in human low density lipoproteins. J Lipid Res, 33, 385-97.
91. KASHIWADA, K., NISHIDA, W., HAYASHI, K., OZAWA, K., YAMANAKA, Y., SAGA, H., YAMASHITA, T., TOHYAMA, M., SHIMADA, S., SATO, K. & SOBUE, K. 1997. Coordinate expression of alpha-tropomyosin and caldesmon isoforms in association with phenotypic modulation of smooth muscle cells. J Biol Chem, 272, 15396-404.
92. KASIMANICKAM, R. K., KASIMANICKAM, V. R., HALDORSON, G. J. & TIBARY, A. 2012. Effect of tocopherol supplementation during last trimester of pregnancy on mRNA abundances of interleukins and angiogenesis in ovine placenta and uterus. Reprod Biol Endocrinol, 10, 4.
93. KASIMANICKAM, R. K., KASIMANICKAM, V. R., RODRIGUEZ, J. S., PELZER, K. D., SPONENEBERG, P. D. & THATCHER, C. D. 2010. Tocopherol induced angiogenesis in placental vascular network in late pregnant ewes. Reprod Biol Endocrinol, 8, 86.
94. KAZI, A. S., LOTFI, S., GONCHAROVA, E. A., TLIBA, O., AMRANI, Y., KRYMSKAYA, V. P. & LAZAAR, A. L. 2004. Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent. Am J Physiol Lung Cell Mol Physiol, 286, L539-45.
95. KAZI, M., LUNDMARK, K., RELIGA, P., GOUDA, I., LARM, O., RAY, A., SWEDENBORG, J. & HEDIN, U. 2002. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins. J Cell Physiol, 193, 365-72.
96. KEMPNA, P., REITER, E., AROCK, M., AZZI, A. & ZINGG, J. M. 2004. Inhibition of HMC-1 mast cell proliferation by vitamin E: Involvement of the protein kinase B pathway. J Biol Chem, 279, 50700-9.
97. KEMPNA, P., RICCIARELLI, R., AZZI, A. & ZINGG, J. M. 2010. Alternative splicing and gene polymorphism of the human TAP3/SEC14L4 gene. Mol Biol Rep, 37, 3503-8.
98. KEMPNA, P., ZINGG, J. M., RICCIARELLI, R., HIERL, M., SAXENA, S. & AZZI, A. 2003. Cloning of novel human SEC14p-like proteins: Cellular localization, ligand binding and functional properties. Free Radic Biol Med, 34, 1458-1472.
99. KHANNA, S., ROY, S., RYU, H., BAHADDURI, P., SWAAN, P. W., RATAN, R. R. & SEN, C. K. 2003. Molecular basis of vitamin E action. Tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J Biol Chem, 278, 43508-15.
100. KINLAY, S., BEHRENDT, D., FANG, J. C., DELAGRANGE, D., MORROW, J., WITZTUM, J. L., RIFAI, N., SELWYN, A. P., CREAGER, M. A. & GANZ, P. 2004. Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol, 43, 629-34.
101. KIPP, D., WILSON, S., GOSIEWSKA, A. & PETERKOFSKY, B. 1995. Differential regulation of collagen gene expression in granulation tissue and non-repair connective tissues in vitamin C-deficient guinea pigs. Wound Repair Regen, 3, 192-203.
102. KOCHER, O., GABBIANI, F., GABBIANI, G., REIDY, M. A., COKAY, M. S., PETERS, H. & HUTTNER, I. 1991. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Biochemical and morphologic studies. Lab Invest, 65, 459-70.
103. KOLLECK, I., SCHLAME, M., FECHNER, H., LOOMAN, A. C., WISSEL, H. & RUSTOW, B. 1999. HDL is the major source of vitamin E for type II pneumocytes. Free Radic Biol Med, 27, 882-90.
104. KOSTNER, G. M., OETTL, K., JAUHIAINEN, M., EHNHOLM, C., ESTERBAUER, H. & DIEPLINGER, H. 1995. Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells. Biochem J, 305, 659-67.
105. KOYA, D. & KING, G. L. 1998. Protein kinase C activation and the development of diabetic complications. Diabetes, 47, 859-66.
106. KOYA, D., LEE, I. K., ISHII, H., KANOH, H. & KING, G. L. 1997. Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J Am Soc Nephrol, 8, 426-35.
107. KOYAMA, H., RAINES, E. W., BORNFELDT, K. E., ROBERTS, J. M. & ROSS, R. 1996. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell, 87, 1069-78.
108. KUNSCH, C. & MEDFORD, R. M. 1999. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res, 85, 753-66.
109. KURATA, S., SENOO, H. & HATA, R. 1993. Transcriptional activation of type I collagen genes by ascorbic acid 2-phosphate in human skin fibroblasts and its failure in cells from a patient with alpha 2(I)-chain-defective Ehlers-Danlos syndrome. Exp Cell Res, 206, 63-71.
110. LANDES, N., PFLUGER, P., KLUTH, D., BIRRINGER, M., RUHL, R., BOL, G. F., GLATT, H. & BRIGELIUS-FLOHE, R. 2003. Vitamin E activates gene expression via the pregnane X receptor. Biochem Pharmacol, 65, 269-73.
111. LECOMPTE, S., SZABO DE EDELENYI, F., GOUMIDI, L., MAIANI, G., MOSCHONIS, G., WIDHALM, K., MOLNAR, D., KAFATOS, A., SPINNEKER, A., BREIDENASSEL, C., DALLONGEVILLE, J., MEIRHAEGHE, A. & BOREL, P. 2011. Polymorphisms in the CD36/FAT gene are associated with plasma vitamin E concentrations in humans. Am J Clin Nutr, 93, 644-51.
112. LEHR, H. A., FREI, B. & ARFORS, K. E. 1994. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci U S A, 91, 7688-92.
113. LEHR, H. A., FREI, B., OLOFSSON, A. M., CAREW, T. E. & ARFORS, K. E. 1995. Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. Circulation, 91, 1525-32.
114. LEHR, H. A., WEYRICH, A. S., SAETZLER, R. K., JUREK, A., ARFORS, K. E., ZIMMERMAN, G. A., PRESCOTT, S. M. & MCINTYRE, T. M. 1997. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J Clin Invest, 99, 2358-64.
115. LEMAIRE-EWING, S., DESRUMAUX, C., NEEL, D. & LAGROST, L. 2010. Vitamin E transport, membrane incorporation and cell metabolism: Is alpha-tocopherol in lipid rafts an oar in the lifeboat? Mol Nutr Food Res, 54, 631-40.
116. LENER, T., BURGSTALLER, G., CRIMALDI, L., LACH, S. & GIMONA, M. 2006. Matrix-degrading podosomes in smooth muscle cells. Eur J Cell Biol, 85, 183-9.
117. LEVINE, M. 1986. New concepts in the biology and biochemistry of ascorbic acid. N Engl J Med, 314, 892-902.
118. LI, L., MAMPUTU, J. C., WIERNSPERGER, N. & RENIER, G. 2005. Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. Diabetes, 54, 2227-34.
119. LI, W., HELLSTEN, A., JACOBSSON, L. S., BLOMQVIST, H. M., OLSSON, A. G. & YUAN, X. M. 2004. Alpha-tocopherol and astaxanthin decrease macrophage infiltration, apoptosis and vulnerability in atheroma of hyperlipidaemic rabbits. J Mol Cell Cardiol, 37, 969-78.
120. LIU, L. & MEYDANI, M. 2002. Combined vitamin C and E supplementation retards early progression of arteriosclerosis in heart transplant patients. Nutr Rev, 60, 368-71.
121. LOVE-GREGORY, L., SHERVA, R., SCHAPPE, T., QI, J. S., MCCREA, J., KLEIN, S., CONNELLY, M. A. & ABUMRAD, N. A. 2011. Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile. Hum Mol Genet, 20, 193-201.
122. LOVE-GREGORY, L., SHERVA, R., SUN, L., WASSON, J., SCHAPPE, T., DORIA, A., RAO, D. C., HUNT, S. C., KLEIN, S., NEUMAN, R. J., PERMUTT, M. A. & ABUMRAD, N. A. 2008. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet, 17, 1695-704.
123. LUNA, J., MASAMUNT, M. C., LLACH, J., DELGADO, S. & SANS, M. 2011a. Palm oil tocotrienol rich fraction reduces extracellular matrix production by inhibiting transforming growth factor-beta1 in human intestinal fibroblasts. Clin Nutr, 30, 858-64.
124. LUNA, J., MASAMUNT, M. C., RICKMANN, M., MORA, R., ESPANA, C., DELGADO, S., LLACH, J., VAQUERO, E. & SANS, M. 2011b. Tocotrienols have potent antifibrogenic effects in human intestinal fibroblasts. Inflamm Bowel Dis, 17, 732-41.
125. LYNCH, S. M., GAZIANO, J. M. & FREI, B. 1996. Ascorbic acid and atherosclerotic cardiovascular disease. Subcell Biochem, 25, 331-67.
126. MA, X., BACCI, S., MLYNARSKI, W., GOTTARDO, L., SOCCIO, T., MENZAGHI, C., IORI, E., LAGER, R. A., SHROFF, A. R., GERVINO, E. V., NESTO, R. W., JOHNSTONE, M. T., ABUMRAD, N. A., AVOGARO, A., TRISCHITTA, V. & DORIA, A. 2004. A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum Mol Genet, 13, 2197-205.
127. MAEDA, N., HAGIHARA, H., NAKATA, Y., HILLER, S., WILDER, J. & REDDICK, R. 2000. Aortic wall damage in mice unable to synthesize ascorbic acid. Proc Natl Acad Sci U S A, 97, 841-6.
128. MARCHIOLI, R. 1999. Antioxidant vitamins and prevention of cardiovascular disease: Laboratory, epidemiological and clinical trial data [In Process Citation]. Pharmacol Res, 40, 227-38.
129. MARDONES, P. & RIGOTTI, A. 2004. Cellular mechanisms of vitamin E uptake: relevance in alpha-tocopherol metabolism and potential implications for disease. J Nutr Biochem, 15, 252-60.
130. MARDONES, P., STROBEL, P., MIRANDA, S., LEIGHTON, F., QUINONES, V., AMIGO, L., ROZOWSKI, J., KRIEGER, M. & RIGOTTI, A. 2002a. Alpha-tocopherol metabolism is abnormal in scavenger receptor class B type I (SR-BI)-deficient mice. J Nutr, 132, 443-9.
131. MARTIN, A. & FREI, B. 1997. Both intracellular and extracellular vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells. Arterioscler Thromb Vasc Biol, 17, 1583-90.
132. MAUCH, S., KOLB, C., KOLB, B., SADOWSKI, T. & SEDLACEK, R. 2002. Matrix metalloproteinase-19 is expressed in myeloid cells in an adhesion-dependent manner and associates with the cell surface. J Immunol, 168, 1244-51.
133. MAY, J. M. 1999. Is ascorbic acid an antioxidant for the plasma membrane? FASEB J, 13, 995-1006.
134. MAY, J. M., COBB, C. E., MENDIRATTA, S., HILL, K. E. & BURK, R. F. 1998. Reduction of the ascorbyl free radical to ascorbate by thioredoxin reductase. J Biol Chem, 273, 23039-45.
135. MAY, J. M., QU, Z. C. & COBB, C. E. 2004. Human erythrocyte recycling of ascorbic acid: Relative contributions from the ascorbate free radical and dehydroascorbic acid. J Biol Chem, 279, 14975-82.
136. MCCARY, C. A., YOON, Y., PANAGABKO, C., CHO, W., ATKINSON, J. & COOK-MILLS, J. M. 2012. Vitamin E isoforms directly bind PKCalpha and differentially regulate activation of PKCalpha. Biochem J, 441, 189-98.
137. MILMAN, U., BLUM, S., SHAPIRA, C., ARONSON, D., MILLER-LOTAN, R., ANBINDER, Y., ALSHIEK, J., BENNETT, L., KOSTENKO, M., LANDAU, M., KEIDAR, S., LEVY, Y., KHEMLIN, A., RADAN, A. & LEVY, A. P. 2008. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: A prospective double-blinded clinical trial. Arterioscler Thromb Vasc Biol, 28, 341-7.
138. MORI, Y., HATAMOCHI, A., TAKEDA, K. & UEKI, H. 1994. Effects of tretinoin tocoferil on gene expression of the extracellular matrix components in human dermal fibroblasts in vitro. J Dermatol Sci, 8, 233-8.
139. MORLEY, S., THAKUR, V., DANIELPOUR, D., PARKER, R., ARAI, H., ATKINSON, J., BARNHOLTZ-SLOAN, J., KLEIN, E. & MANOR, D. 2010. Tocopherol transfer protein sensitizes prostate cancer cells to vitamin E. J Biol Chem, 285, 35578-89.
140. MULVIHILL, E. R., JAEGER, J., SENGUPTA, R., RUZZO, W. L., REIMER, C., LUKITO, S. & SCHWARTZ, S. M. 2004. Atherosclerotic plaque smooth muscle cells have a distinct phenotype. Arterioscler Thromb Vasc Biol, 24, 1283-9.
141. MUNTEANU, A., TADDEI, M., TAMBURINI, I., BERGAMINI, E., AZZI, A. & ZINGG, J. M. 2006. Antagonistic effects of oxidized low density lipoprotein and alpha-tocopherol on CD36 scavenger receptor expression in monocytes: Involvement of protein kinase B and peroxisome proliferator-activated receptor-gamma. J Biol Chem, 281, 6489-97.
142. MUNTEANU, A. & ZINGG, J. M. 2007. Cellular, molecular and clinical aspects of vitamin E on atherosclerosis prevention. Mol Aspects Med, 28, 538-590.
143. MUNTEANU, A., ZINGG, J. M. & AZZI, A. 2004. Anti-atherosclerotic effects of vitamin E: Myth or reality? J Cell Mol Med, 8, 59-76.
144. MUSTACICH, D. J., VO, A. T., ELIAS, V. D., PAYNE, K., SULLIVAN, L., LEONARD, S. W. & TRABER, M. G. 2007. Regulatory mechanisms to control tissue alpha-tocopherol. Free Radic Biol Med, 43, 610-8.
145. NA, N., DELANGHE, J. R., TAES, Y. E., TORCK, M., BAEYENS, W. R. & OUYANG, J. 2006. Serum vitamin C concentration is influenced by haptoglobin polymorphism and iron status in Chinese. Clin Chim Acta, 365, 319-24.
146. NAIDU, K. A. 2003. Vitamin C in human health and disease is still a mystery? An overview. Nutr J, 2, 7.
147. NAKATA, Y. & MAEDA, N. 2002. Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic acid. Circulation, 105, 1485-90.
148. NAPOLI, C., WILLIAMS-IGNARRO, S., DE NIGRIS, F., LERMAN, L. O., ROSSI, L., GUARINO, C., MANSUETO, G., DI TUORO, F., PIGNALOSA, O., DE ROSA, G., SICA, V. & IGNARRO, L. J. 2004. Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc Natl Acad Sci U S A, 101, 8797-802.
149. NARUSHIMA, K., TAKADA, T., YAMANASHI, Y. & SUZUKI, H. 2008. Niemann-Pick C1-like 1 mediates alpha-tocopherol transport. Mol Pharmacol, 74, 42-9.
150. NESPEREIRA, B., PEREZ-ILZARBE, M., FERNANDEZ, P., FUENTES, A. M., PARAMO, J. A. & RODRIGUEZ, J. A. 2003. Vitamins C and E downregulate vascular VEGF and VEGFR-2 expression in apolipoprotein-E-deficient mice. Atherosclerosis, 171, 67-73.
151. NESS, A., EGGER, M. & SMITH, G. D. 1999. Role of antioxidant vitamins in prevention of cardiovascular diseases. Meta-analysis seems to exclude benefit of vitamin C supplementation. BMJ, 319, 577.
152. NEUVILLE, P., GEINOZ, A., BENZONANA, G., REDARD, M., GABBIANI, F., ROPRAZ, P. & GABBIANI, G. 1997. Cellular retinol-binding protein-1 is expressed by distinct subsets of rat arterial smooth muscle cells in vitro and in vivo. Am J Pathol, 150, 509-21.
153. NEUZIL, J., DONG, L. F., WANG, X. F. & ZINGG, J. M. 2006. Tocopherol-associated protein-1 accelerates apoptosis induced by alpha-tocopheryl succinate in mesothelioma cells. Biochem Biophys Res Commun, 343, 1113-7.
154. NI, J., PANG, S. T. & YEH, S. 2007. Differential retention of alpha-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells. Prostate, 67, 463-71.
155. NI, J., WEN, X., YAO, J., CHANG, H. C., YIN, Y., ZHANG, M., XIE, S., CHEN, M., SIMONS, B., CHANG, P., DI SANT’AGNESE, A., MESSING, E. M. & YEH, S. 2005. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Res, 65, 9807-16.
156. NIER, B., WEINBERG, P. D., RIMBACH, G., STOCKLIN, E. & BARELLA, L. 2006. Differential gene expression in skeletal muscle of rats with vitamin E deficiency. IUBMB Life, 58, 540-8.
157. NOEL, S. E., LAI, C. Q., MATTEI, J., PARNELL, L. D., ORDOVAS, J. M. & TUCKER, K. L. 2010. Variants of the CD36 gene and metabolic syndrome in Boston Puerto Rican adults. Atherosclerosis, 211, 210-5.
158. NUMAKAWA, Y., NUMAKAWA, T., MATSUMOTO, T., YAGASAKI, Y., KUMAMARU, E., KUNUGI, H., TAGUCHI, T. & NIKI, E. 2006. Vitamin E protected cultured cortical neurons from oxidative stress-induced cell death through the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. J Neurochem, 97, 1191-202.
159. OEMAR, B. S. & LUSCHER, T. F. 1997. Connective tissue growth factor. Friend or foe? Arterioscler Thromb Vasc Biol, 17, 1483-9.
160. OEMAR, B. S., WERNER, A., GARNIER, J. M., DO, D. D., GODOY, N., NAUCK, M., MARZ, W., RUPP, J., PECH, M. & LUSCHER, T. F. 1997. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation, 95, 831-9.
161. OGIER, N., KLEIN, A., DECKERT, V., ATHIAS, A., BESSEDE, G., LE GUERN, N., LAGROST, L. & DESRUMAUX, C. 2007. Cholesterol accumulation is increased in macrophages of phospholipid transfer protein-deficient mice: Normalization by dietary alpha-tocopherol supplementation. Arterioscler Thromb Vasc Biol, 27, 2407-12.
162. OOMMEN, S., VASU, V. T., LEONARD, S. W., TRABER, M. G., CROSS, C. E. & GOHIL, K. 2007. Genome wide responses of murine lungs to dietary alpha-tocopherol. Free Radic Res, 41, 98-109.
163. ORAM, J. F., VAUGHAN, A. M. & STOCKER, R. 2001. ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol. J Biol Chem, 276, 39898-902.
164. ORBE, J., RODRIGUEZ, J. A., ARIAS, R., BELZUNCE, M., NESPEREIRA, B., PEREZ-ILZARBE, M., RONCAL, C. & PARAMO, J. A. 2003. Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: Implications for plaque stabilization. Atherosclerosis, 167, 45-53.
165. ORLANDI, A., EHRLICH, H. P., ROPRAZ, P., SPAGNOLI, L. G. & GABBIANI, G. 1994. Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro. Arterioscler Thromb, 14, 982-9.
166. OZER, N. K., BOSCOBOINIK, D. & AZZI, A. 1995. New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis. Biochem Mol Biol Int, 35, 117-24.
167. PADAYATTY, S. J., KATZ, A., WANG, Y., ECK, P., KWON, O., LEE, J. H., CHEN, S., CORPE, C., DUTTA, A., DUTTA, S. K. & LEVINE, M. 2003. Vitamin C as an antioxidant: Evaluation of its role in disease prevention. J Am Coll Nutr, 22, 18-35.
168. PADH, H. 1991. Vitamin C: Newer insights into its biochemical functions. Nutr Rev, 49, 65-70.
169. PARK, J. Y., HA, S. W. & KING, G. L. 1999. The role of protein kinase C activation in the pathogenesis of diabetic vascular complications. Perit Dial Int, 19 Suppl 2, S222-7.
170. PATEL, J., MATNOR, N. A., IYER, A. & BROWN, L. 2011. A regenerative antioxidant protocol of vitamin E and alpha-lipoic acid ameliorates cardiovascular and metabolic changes in fructose-red rats. Evid Based Complement Alternat Med, 2011, 120801.
171. PETERSZEGI, G., DAGONET, F. B., LABAT-ROBERT, J. & ROBERT, L. 2002. Inhibition of cell proliferation and fibronectin biosynthesis by Na ascorbate. Eur J Clin Invest, 32, 372-80.
172. PINNEL, S. R., MURAD, S. & DARR, D. 1987. Induction of collagen synthesis by ascorbic acid. A possible mechanism. Arch Dermatol, 123, 1684-6.
173. PORTER, T. D. 2003. Supernatant protein factor and tocopherol-associated protein: An unexpected link between cholesterol synthesis and vitamin E (review). J Nutr Biochem, 14, 3-6.
174. QUAGLINO, D., FORNIERI, C., BOTTI, B., DAVIDSON, J. M. & PASQUALI-RONCHETTI, I. 1991. Opposing effects of ascorbate on collagen and elastin deposition in the neonatal rat aorta. Eur J Cell Biol, 54, 18-26.
175. RAINES, E. W. 2000. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: Relationships to vascular disease. Int J Exp Pathol, 81, 173-82.
176. RASK-MADSEN, C. & KING, G. L. 2005. Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance. Arterioscler Thromb Vasc Biol, 25, 487-96.
177. REBOUL, E., KLEIN, A., BIETRIX, F., GLEIZE, B., MALEZET-DESMOULINS, C., SCHNEIDER, M., MARGOTAT, A., LAGROST, L., COLLET, X. & BOREL, P. 2006. Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. J Biol Chem, 281, 4739-4745.
178. REDDANNA, P., RAO, M. K. & REDDY, C. C. 1985. Inhibition of 5-lipoxygenase by vitamin E. FEBS Lett, 193, 39-43.
179. REN, G., CRAMPTON, M. S. & YAP, A. S. 2009. Cortactin: Coordinating adhesion and the actin cytoskeleton at cellular protrusions. Cell Motil Cytoskeleton, 66, 865-73.
180. RICCIARELLI, R., MARONI, P., OZER, N., ZINGG, J. M. & AZZI, A. 1999. Age-dependent increase of collagenase expression can be reduced by alpha-tocopherol via protein kinase C inhibition. Free Radic Biol Med, 27, 729-37.
181. RICCIARELLI, R., TASINATO, A., CLEMENT, S., OZER, N. K., BOSCOBOINIK, D. & AZZI, A. 1998. Alpha-tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem J, 334, 243-9.
182. RICCIARELLI, R., ZINGG, J. M. & AZZI, A. 2000. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation, 102, 82-7.
183. RICCIARELLI, R., ZINGG, J. M. & AZZI, A. 2001. Vitamin E: Protective role of a Janus molecule. FASEB J, 15, 2314-25.
184. RIGOTTI, A. 2007. Absorption, transport, and tissue delivery of vitamin E. Mol Aspects Med, 28, 423-36.
185. ROSENFELD, L. 1997. Vitamine-vitamin. The early years of discovery. Clin Chem, 43, 680-5.
186. RUHRBERG, C. 2003. Growing and shaping the vascular tree: Multiple roles for VEGF. Bioessays, 25, 1052-60.
187. SAITOH, Y., YUMOTO, A. & MIWA, N. 2009. Alpha-tocopheryl phosphate suppresses tumor invasion concurrently with dynamic morphological changes and delocalization of cortactin from invadopodia. Int J Oncol, 35, 1277-88.
188. SALONEN, J. T., NYYSSONEN, K., SALONEN, R., LAKKA, H. M., KAIKKONEN, J., PORKKALA-SARATAHO, E., VOUTILAINEN, S., LAKKA, T. A., RISSANEN, T., LESKINEN, L., TUOMAINEN, T. P., VALKONEN, V. P., RISTONMAA, U. & POULSEN, H. E. 2000. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: A randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med, 248, 377-86.
189. SAMANDARI, E., VISARIUS, T., ZINGG, J. M. & AZZI, A. 2006. The effect of gamma-tocopherol on proliferation, integrin expression, adhesion, and migration of human glioma cells. Biochem Biophys Res Commun, 342, 1329-33.
190. SANYAL, A. J., CHALASANI, N., KOWDLEY, K. V., MCCULLOUGH, A., DIEHL, A. M., BASS, N. M., NEUSCHWANDER-TETRI, B. A., LAVINE, J. E., TONASCIA, J., UNALP, A., VAN NATTA, M., CLARK, J., BRUNT, E. M., KLEINER, D. E., HOOFNAGLE, J. H. & ROBUCK, P. R. 2010. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med, 362, 1675-85.
191. SATO, K., NIKI, E. & SHIMASAKI, H. 1990. Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Arch Biochem Biophys, 279, 402-5.
192. SATO, Y., ARAI, H., MIYATA, A., TOKITA, S., YAMAMOTO, K., TANABE, T. & INOUE, K. 1993. Primary structure of alpha-tocopherol transfer protein from rat liver. Homology with cellular retinaldehyde-binding protein. J Biol Chem, 268, 17705-10.
193. SATO, Y., HAGIWARA, K., ARAI, H. & INOUE, K. 1991. Purification and characterization of the alpha-tocopherol transfer protein from rat liver. FEBS Lett, 288, 41-5.
194. SAYED-AHMED, M. M., KHATTAB, M. M., GAD, M. Z. & MOSTAFA, N. 2001. L-carnitine prevents the progression of atherosclerotic lesions in hypercholesterolaemic rabbits. Pharmacol Res, 44, 235-42.
195. SCHGOER, W., MUELLER, T., JAUHIAINEN, M., WEHINGER, A., GANDER, R., TANCEVSKI, I., SALZMANN, K., ELLER, P., RITSCH, A., HALTMAYER, M., EHNHOLM, C., PATSCH, J. R. & FOEGER, B. 2008. Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis. Atherosclerosis, 196, 219-26.
196. SCHINDLER, R. & MENTLEIN, R. 2006. Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J Nutr, 136, 1477-82.
197. SCHNEIDER, M., VERGES, B., KLEIN, A., MILLER, E. R., DECKERT, V., DESRUMAUX, C., MASSON, D., GAMBERT, P., BRUN, J. M., FRUCHART-NAJIB, J., BLACHE, D., WITZTUM, J. L. & LAGROST, L. 2004. Alterations in plasma vitamin E distribution in type 2 diabetic patients with elevated plasma phospholipid transfer protein activity. Diabetes, 53, 2633-9.
198. SEN, C. K. & PACKER, L. 1996. Antioxidant and redox regulation of gene transcription. FASEB J, 10, 709-20.
199. SENO, T., INOUE, N., MATSUI, K., EJIRI, J., HIRATA, K., KAWASHIMA, S. & YOKOYAMA, M. 2004. Functional expression of sodium-dependent vitamin C transporter 2 in human endothelial cells. J Vasc Res, 41, 345-51.
200. SHIBAYAMA, H., HISAMA, M., MATSUDA, S., OHTSUKI, M. & IWAKI, M. 2008. Effect of a novel ascorbic derivative, disodium isostearyl 2-O-L-ascorbyl phosphate on human dermal fibroblasts: Increased collagen synthesis and inhibition of MMP-1. Biol Pharm Bull, 31, 563-8.
201. SHINOMIYA, K., FUKUNAGA, M., KIYOMOTO, H., MIZUSHIGE, K., TSUJI, T., NOMA, T., OHMORI, K., KOHNO, M. & SENDA, S. 2002. A role of oxidative stress-generated eicosanoid in the progression of arteriosclerosis in type 2 diabetes mellitus model rats. Hypertens Res, 25, 91-8.
202. SIOW, R. C., RICHARDS, J. P., PEDLEY, K. C., LEAKE, D. S. & MANN, G. E. 1999a. Vitamin C protects human vascular smooth muscle cells against apoptosis induced by moderately oxidized LDL containing high levels of lipid hydroperoxides. Arterioscler Thromb Vasc Biol, 19, 2387-94.
203. SIOW, R. C., SATO, H., LEAKE, D. S., ISHII, T., BANNAI, S. & MANN, G. E. 1999b. Induction of antioxidant stress proteins in vascular endothelial and smooth muscle cells: Protective action of vitamin C against atherogenic lipoproteins. Free Radic Res, 31, 309-18.
204. SIRIKCI, O., OZER, N. K. & AZZI, A. 1996. Dietary cholesterol-induced changes of protein kinase C and the effect of vitamin E in rabbit aortic smooth muscle cells. Atherosclerosis, 126, 253-63.
205. STAUBLE, B., BOSCOBOINIK, D., TASINATO, A. & AZZI, A. 1994. Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D-alpha-tocopherol in vascular smooth muscle cells. Eur J Biochem, 226, 393-402.
206. STUART, L. M., DENG, J., SILVER, J. M., TAKAHASHI, K., TSENG, A. A., HENNESSY, E. J., EZEKOWITZ, R. A. & MOORE, K. J. 2005. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J Cell Biol, 170, 477-85.
207. SUARNA, C., WU, B. J., CHOY, K., MORI, T., CROFT, K., CYNSHI, O. & STOCKER, R. 2006. Protective effect of vitamin E supplements on experimental atherosclerosis is modest and depends on preexisting vitamin E deficiency. Free Radic Biol Med, 41, 722-30.
208. SUN, Y. & OBERLEY, L. W. 1996. Redox regulation of transcriptional activators. Free Radic Biol Med, 21, 335-48.
209. SUNG, B. H. & WEAVER, A. M. 2011. Regulation of lysosomal secretion by cortactin drives fibronectin deposition and cell motility. Bioarchitecture, 1, 257-60.
210. SUNG, B. H., ZHU, X., KAVERINA, I. & WEAVER, A. M. 2011. Cortactin controls cell motility and lamellipodial dynamics by regulating ECM secretion. Curr Biol, 21, 1460-9.
211. TAKAHASHI, T., LORD, B., SCHULZE, P. C., FRYER, R. M., SARANG, S. S., GULLANS, S. R. & LEE, R. T. 2003. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation, 107, 1912-6.
212. TAKANAGA, H., MACKENZIE, B. & HEDIGER, M. A. 2004. Sodium-dependent ascorbic acid transporter family SLC23. Pflugers Arch, 447, 677-82.
213. TANG, F. Y. & MEYDANI, M. 2001. Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production. Nutr Cancer, 41, 119-25.
214. TAPPEINER, C., MEYENBERG, A., GOLDBLUM, D., MOJON, D., ZINGG, J. M., NESARETNAM, K., KILCHENMANN, M. & FRUEH, B. E. 2010. Antifibrotic effects of tocotrienols on human Tenon’s fibroblasts. Graefes Arch Clin Exp Ophthalmol,248(1), 65-71.
215. TASINATO, A., BOSCOBOINIK, D., BARTOLI, G. M., MARONI, P. & AZZI, A. 1995. D-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc Natl Acad Sci U S A, 92, 12190-4.
216. TERASAWA, Y., LADHA, Z., LEONARD, S. W., MORROW, J. D., NEWLAND, D., SANAN, D., PACKER, L., TRABER, M. G. & FARESE, R. V., JR. 2000. Increased atherosclerosis in hyperlipidemic mice deficient in alpha-tocopherol transfer protein and vitamin E. Proc Natl Acad Sci U S A, 97, 13830-4.
217. TINKER, D. & RUCKER, R. B. 1985. Role of selected nutrients in synthesis, accumulation, and chemical modification of connective tissue proteins. Physiol Rev, 65, 607-57.
218. TRIANTAFILOU, M., GAMPER, F. G., HASTON, R. M., MOURATIS, M. A., MORATH, S., HARTUNG, T. & TRIANTAFILOU, K. 2006. Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem, 281, 31002-11.
219. ULRICH-MERZENICH, G., METZNER, C., SCHIERMEYER, B. & VETTER, H. 2002. Vitamin C and vitamin E antagonistically modulate human vascular endothelial and smooth muscle cell DNA synthesis and proliferation. Eur J Nutr, 41, 27-34.
220. UPSTON, J. M., KRITHARIDES, L. & STOCKER, R. 2003. The role of vitamin E in atherosclerosis. Prog Lipid Res, 42, 405-22.
221. VAN GOETHEM, E., GUIET, R., BALOR, S., CHARRIERE, G. M., POINCLOUX, R., LABROUSSE, A., MARIDONNEAU-PARINI, I. & LE CABEC, V. 2011. Macrophage podosomes go 3D. Eur J Cell Biol, 90, 224-36.
222. VASU, V. T., HOBSON, B., GOHIL, K. & CROSS, C. E. 2007. Genome-wide screening of alpha-tocopherol sensitive genes in heart tissue from alpha-tocopherol transfer protein null mice (ATTP(-/-)). FEBS Lett, 581, 1572-8.
223. VILLACORTA, L., AZZI, A. & ZINGG, J. M. 2007. Regulatory role of vitamin E and C on extracellular matrix components of the vascular system. Mol Aspects Med, 28, 507-37.
224. VILLACORTA, L., GRACA-SOUZA, A. V., RICCIARELLI, R., ZINGG, J. M. & AZZI, A. 2003. Alpha-tocopherol induces expression of connective tissue growth factor and antagonizes tumor necrosis factor-alpha-mediated downregulation in human smooth muscle cells. Circ Res, 92, 104-10.
225. VOEGELE, A. F., JERKOVIC, L., WELLENZOHN, B., ELLER, P., KRONENBERG, F., LIEDL, K. R. & DIEPLINGER, H. 2002. Characterization of the vitamin E-binding properties of human plasma afamin. Biochemistry, 41, 14532-8.
226. WANG, H. & KEISER, J. A. 1998. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1. Circ Res, 83, 832-40.
227. WANG, X., LEMAIRE, S. A., CHEN, L., SHEN, Y. H., GAN, Y., BARTSCH, H., CARTER, S. A., UTAMA, B., OU, H., COSELLI, J. S. & WANG, X. L. 2006. Increased collagen deposition and elevated expression of connective tissue growth factor in human thoracic aortic dissection. Circulation, 114, I200-5.
228. WASHBURN, M. P. & WELLS, W. W. 1999. The catalytic mechanism of the glutathione-dependent dehydroascorbate reductase activity of thioltransferase (glutaredoxin). Biochemistry, 38, 268-74.
229. WAY, K. J., KATAI, N. & KING, G. L. 2001. Protein kinase C and the development of diabetic vascular complications. Diabet Med, 18, 945-59.
230. WHITBREAD, A. K., MASOUMI, A., TETLOW, N., SCHMUCK, E., COGGAN, M. & BOARD, P. G. 2005. Characterization of the omega class of glutathione transferases. Methods Enzymol, 401, 78-99.
231. WIEGMAN, P. J., BARRY, W. L., MCPHERSON, J. A., MCNAMARA, C. A., GIMPLE, L. W., SANDERS, J. M., BISHOP, G. G., POWERS, E. R., RAGOSTA, M., OWENS, G. K. & SAREMBOCK, I. J. 2000. All-trans-retinoic acid limits restenosis after balloon angioplasty in the focally atherosclerotic rabbit: A favorable effect on vessel remodeling. Arterioscler Thromb Vasc Biol, 20, 89-95.
232. WITZTUM, J. L. & STEINBERG, D. 1991. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest, 88, 1785-92.
233. WODZINSKA, J. M. 2005. Transglutaminases as targets for pharmacological inhibition. Mini Rev Med Chem, 5, 279-92.
234. WONG, B. W., RAHMANI, M., LUO, Z., YANAGAWA, B., WONG, D., LUO, H. & MCMANUS, B. M. 2009. Vascular endothelial growth factor increases human cardiac microvascular endothelial cell permeability to low-density lipoproteins. J Heart Lung Transplant, 28, 950-7.
235. WRIGHT, M. E., PETERS, U., GUNTER, M. J., MOORE, S. C., LAWSON, K. A., YEAGER, M., WEINSTEIN, S. J., SNYDER, K., VIRTAMO, J. & ALBANES, D. 2009. Association of variants in two vitamin E transport genes with circulating vitamin E concentrations and prostate cancer risk. Cancer Res, 69, 1429-38.
236. YOU, H., YU, W., SANDERS, B. G. & KLINE, K. 2001. RRR-alpha-tocopheryl succinate induces MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation. Cell Growth Differ, 12, 471-80.
237. YUASA-KAWASE, M., MASUDA, D., YAMASHITA, T., KAWASE, R., NAKAOKA, H., INAGAKI, M., NAKATANI, K., TSUBAKIO-YAMAMOTO, K., OHAMA, T., MATSUYAMA, A., NISHIDA, M., ISHIGAMI, M., KAWAMOTO, T., KOMURO, I. & YAMASHITA, S. 2012. Patients with CD36 deficiency are associated with enhanced atherosclerotic cardiovascular diseases. J Atheroscler Thromb,19(3), 263-75.
238. ZHANG, B., TANAKA, J., YANG, L., SAKANAKA, M., HATA, R., MAEDA, N. & MITSUDA, N. 2004a. Protective effect of vitamin E against focal brain ischemia and neuronal death through induction of target genes of hypoxia-inducible factor-1. Neuroscience, 126, 433-40.
239. ZHANG, M., ALTUWAIJRI, S. & YEH, S. 2004b. RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness. Oncogene, 23, 3080-8.
240. ZHU, X. Y., RODRIGUEZ-PORCEL, M., BENTLEY, M. D., CHADE, A. R., SICA, V., NAPOLI, C., CAPLICE, N., RITMAN, E. L., LERMAN, A. & LERMAN, L. O. 2004. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation, 109, 2109-15.
241. ZIMMER, S., STOCKER, A., SARBOLOUKI, M. N., SPYCHER, S. E., SASSOON, J. & AZZI, A. 2000. A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization. J Biol Chem, 275, 25672-80.
242. ZINGG, J. M. 2007a. Modulation of signal transduction by vitamin E. Mol Aspects Med, 28, 481-506.
243. ZINGG, J. M. 2007b. Molecular and cellular activities of vitamin E analogues. Mini Rev Med Chem, 7, 543-58.
244. ZINGG, J. M. 2012. Vitamin E and disease risk: Research focus turns on genetic polymorphisms and molecular mechanisms. Vitam Trace Elem, 1, e110.
245. ZINGG, J. M. & AZZI, A. 2004. Non-antioxidant activities of vitamin E. Cur Med Chem, 11, 1113-133.
246. ZINGG, J. M. & AZZI, A. 2007. Smooth Muscle Cells and Alpha-Tocopherol, Wallingford, Oxfordshire, UK: CABI International.
247. ZINGG, J. M. & AZZI, A. 2009. Comment re: Vitamin E transport gene variants and prostate cancer. Cancer Res, 69, 6756; author reply 6756.
248. ZINGG, J. M., AZZI, A. & MEYDANI, M. 2008a. Genetic polymorphisms as determinants for disease-preventive effects of vitamin E. Nutr Rev, 66, 406-14.
249. ZINGG, J. M., KEMPNA, P., PARIS, M., REITER, E., VILLACORTA, L., CIPOLLONE, R., MUNTEANU, A., DE PASCALE, C., MENINI, S., CUEFF, A., AROCK, M., AZZI, A. & RICCIARELLI, R. 2008b. Characterization of three human sec14p-like proteins: Alpha-tocopherol transport activity and expression pattern in tissues. Biochimie, 90, 1703-15.
250. ZINGG, J. M., LIBINAKI, R., LAI, C. Q., MEYDANI, M., GIANELLO, R., OGRU, E. & AZZI, A. 2010. Modulation of gene expression by alpha-tocopherol and alpha-tocopheryl phosphate in THP-1 monocytes. FRBM, 49, 1989-2000.
251. ZINGG, J. M., MEYDANI, M. & AZZI, A. 2012. Alpha-tocopheryl phosphate: An activated form of vitamin E important for angiogenesis and vasculogenesis? Biofactors, 38, 24-33.
252. ZINGG, J. M., RICCIARELLI, R., ANDORNO, E. & AZZI, A. 2002. Novel 5' exon of scavenger receptor CD36 is expressed in cultured human vascular smooth muscle cells and atherosclerotic plaques. Arterioscler Thromb Vasc Biol, 22, 412-7.